salicylhydroxamic acid (SHAM)

Subscribe to Selected New Research on salicylhydroxamic acid

9886 relevant articles (320 outcomes, 811 trials/studies) found for this Bio-Agent

Description: structure

Also Known As:

SHAM; salicylhydroxamate

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 42

Amides: 156

Salicylamides: 1

salicylhydroxamic acid: 9886

Experts

1.	Fregni, Felipe: 4 articles (12/2007 - 05/2006)
2.	Rigonatti, Sergio P: 4 articles (12/2007 - 05/2006)
3.	Boggio, Paulo S: 4 articles (12/2007 - 05/2006)
4.	Wayne, Peter M: 3 articles (10/2008 - 12/2005)
5.	Schnyer, Rosa N: 3 articles (10/2008 - 06/2007)
6.	Stovner, L J: 3 articles (01/2008 - 10/2004)
7.	Valle, Angela C: 3 articles (12/2007 - 08/2006)
8.	Freedman, Steven D: 3 articles (12/2006 - 05/2006)
9.	Pascual-Leone, Alvaro: 3 articles (12/2006 - 05/2006)
10.	Ferreira, Merari J L: 3 articles (12/2006 - 05/2006)

Related Diseases

1.	Pain (Aches) 08/01/2006 - "To date, there has been no successful clinical study focused on establishing the efficacy of neurostimulation for pain and incorporating sufficient numbers of participants, matched control groups, sham stimulation, randomization, prospectively defined end points, and methods for controlling experimental bias. " 01/01/2004 - "Data collected from the study indicate both a decrease in VS pain scores and a significant improvement (p = 0.05) in physician assessment in subjects treated with active devices compared to those treated with the sham device." 03/01/1999 - "The high-quality study suggests that real acupuncture is more effective than sham acupuncture for relieving pain, increasing pain thresholds, improving global ratings, and reducing morning stiffness of FMS, but the duration of benefit following the acupuncture treatment series is not known. " 09/01/2009 - "The participants in the acupuncture group reported a significant reduction of pain and improvement of functional status as compared with those in the sham acupuncture and control groups. " 08/05/2009 - "When compared with sham stimulation, cTBS resulted in a significantly greater diminution of pain ratings and N2-P2 amplitudes on the hand contralateral to the site of motor cortex stimulation." Order ALL the reference details at left...
2.	Ischemia 05/05/2004 - "RESULTS: Recovery of left ventricular developed pressure (LVDP) of ischemic hearts treated with CSIL at 1 min of ischemia, assessed at 5 min of reperfusion (98 +/- 14%), was similar to that of sham-operated hearts (100%) but was significantly greater than that of placebo-treated hearts (12 +/- 7%, p = 0.01). " 04/01/2004 - "When beta-AR is being activated during ischemia, the infarct size was significantly greater in Ovx than in the sham and Ovx + E(2) rats. " 02/01/1999 - "Detectable levels of TNF were measured during ischemia in a significantly higher percentage of the IR group compared with SHAM (9 of 12 vs 3 of 12), and the maximal TNF values were also significantly greater (51.1 +/- 12.6 pg/mL vs 5.5 +/- 2.9 pg/mL). " 12/01/1992 - "Ischemia and reperfusion (n = 10) was associated with an increase in CK (6,380 +/- 1,346 U/L, p < 0.05) and LDH (552 +/- 76 U/L, p < 0.05) activities which were significantly greater than those observed in sham-operated control animals (CK 1,651 +/- 207 U/L, LDH 246 +/- 14 U/L; n = 6). " 12/01/1990 - "Intestinal ischemia for 120 minutes was associated with TNF elevation to 1.19 +/- 0.50 U/mL. Reperfusion for periods of 15 and 30 minutes generated 5- to 10-fold increases in circulating TNF levels (6.61 +/- 3.11 U/mL, p greater than 0.05 and 10.41 +/- 5.41 U/mL, p = 0.004 compared to sham); however this increase in circulating TNF was transient and largely cleared within 60 minutes after initiating reperfusion. " Order ALL the reference details at left...
3.	Body Weight (Weight, Body) 11/01/2009 - "Specifically, IL-17-neutralized mice exhibited significantly greater body weight loss, higher organism growth, and much more severe pathological changes in the lung compared with sham-treated control mice. " 01/01/1999 - "Exposure of SL animals to a steady state 60 Hz MF for 3 h/day for 42 days resulted in a statistically significant reduction in body weight (ANOVA: P > .05), compared with sham-exposed SL animals. " 01/01/1998 - "Body weights of the ovariectomized rats were significantly greater than those of sham-operated controls. " 05/01/1990 - "Compared with sham operation, uninephrectomy resulted in a significantly greater kidney-to-body weight ratio 2 and 7 days postsurgery. " 02/01/1989 - "Mean left ventricular mass was significantly greater in the banded compared with sham-operated animals (2.5 +/- 0.9 v 2.1 +/- 0.5 g/kg body weight; P less than .05). " Order ALL the reference details at left...
4.	Infection 01/01/1991 - "Our experimental results showed that thymus weight, content of lymphocytes in thymus and responsiveness to Con A in vitro were dramatically reduced in BDL rats as compared to rats with sham operation and that the impairment of lymphocyte function was significantly related to the susceptibility to infection. " 08/01/2008 - "Unlike its effect on macrophages from both male and female DBA/2 mice, E2 only increased leishmanicidal activity in macrophages from female C57BL/6 mice, which was evident by a significant reduction in both infection rates and infection levels compared to sham controls. " 04/01/2003 - "In the mouse model of Bordetella pertussis respiratory infection, the chimera-immunized animals showed a significant reduction in bacterial lung counts (P = 0.01) from that of the sham control group. " 11/01/2008 - "Lesions induced by Leishmania major infection were reduced by the ingestion of Ova in sensitized mice, as assessed by reduced footpad growth, lower parasite loads and improved pathological outcome compared to sham sensitized mice. " 06/01/1997 - "CD4 T lymphocyte-depleted and sham-depleted mice underwent a similar course of illness with a sublethal rickettsial dose, cleared the infection by day 10, and recovered on days 10 to 11. " Order ALL the reference details at left...
5.	Shock 03/18/2002 - "Electrical stimulation of either the right or left intact vagus nerve conferred significant protection against endotoxin-induced shock, and specifically attenuated serum and myocardial TNF, but not pulmonary TNF synthesis, as compared with sham-operated animals. " 09/01/2000 - "The parameters of MC were improved nearly to the same values as in sham shock group and were markedly higher than in NS treated group. " 06/01/2000 - "The parameters of myocardial contractility were improved nearly to the values in sham shock group and were markedly higher than that in NS alone-treated group. " 10/01/2006 - "Neutrophils infiltrating the liver increased nearly 3-fold in placebo-treated shock mice versus sham (P<0.05); this shock-induced increase in neutrophil infiltration was also eliminated by pretreatment with pOp3. " 06/01/1999 - "Sham-operated rats demonstrated enhanced acquisition after shock exposure; both rostral and caudal lesions eliminated this effect. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Insulin (Novolin)
2.	Creatinine
3.	Captopril (Capoten)
4.	Oxygen
5.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
6.	Dihydrotachysterol (AT 10)
7.	Ethanol (Ethyl Alcohol)
8.	Smoke
9.	Interleukin-6 (Interleukin 6)
10.	Acetylcholine (Acetylcholine Chloride)

Related Therapies and Procedures

1.	Transcutaneous Electric Nerve Stimulation (TENS)
2.	Lasers (Laser)
3.	Ligation
4.	Acupuncture Points (Acupuncture Point)
5.	Transplants (Transplant)

Best Treatments:
Research Summary Report
on Pain

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 9246 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>